☰

Thijs van der Vaart - Publications

Affiliations: 
Erasmus Medical Center Rotterdam, Rotterdam, Netherlands 
Area:
learning and memory
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, Ten Hoopen LW, van der Vaart T, Jansen FE, Elgersma Y, Moll HA, de Wit MY. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology. PMID 31217257 DOI: 10.1212/WNL.0000000000007749  0.502
2017 Rietman AB, van der Vaart T, Plasschaert E, Nicholson BA, Oostenbrink R, Krab LC, Descheemaeker MJ, Wit MY, Moll HA, Legius E, Nijs PFA. Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 29243874 DOI: 10.1002/ajmg.b.32612  0.608
2016 Walsh KS, Janusz J, Wolters PL, Moll HA, van der Vaart T, Rietman AB. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1. Neurology. 86: 1849-50. PMID 27164720 DOI: 10.1212/WNL.0000000000002687  0.349
2015 van der Vaart T, Rietman AB, Plasschaert E, Legius E, Elgersma Y, Moll HA. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1. Neurology. PMID 26519538 DOI: 10.1212/WNL.0000000000002118  0.586
2015 van der Vaart T, Overwater IE, Oostenbrink R, Moll HA, Elgersma Y. Treatment of Cognitive Deficits in Genetic Disorders: A Systematic Review of Clinical Trials of Diet and Drug Treatments. Jama Neurology. 72: 1052-60. PMID 26168015 DOI: 10.1001/jamaneurol.2015.0443  0.517
2015 Omrani A, van der Vaart T, Mientjes E, van Woerden GM, Hojjati MR, Li KW, Gutmann DH, Levelt CN, Smit AB, Silva AJ, Kushner SA, Elgersma Y. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. Molecular Psychiatry. PMID 25917366 DOI: 10.1038/Mp.2015.48  0.555
2013 van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A, de Wit MC, Descheemaeker MJ, Vergouwe Y, Catsman-Berrevoets CE, Legius E, Elgersma Y, Moll HA. Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. The Lancet. Neurology. 12: 1076-83. PMID 24090588 DOI: 10.1016/S1474-4422(13)70227-8  0.59
2011 van der Vaart T, van Woerden GM, Elgersma Y, de Zeeuw CI, Schonewille M. Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum. Genes, Brain, and Behavior. 10: 404-9. PMID 21352477 DOI: 10.1111/J.1601-183X.2011.00685.X  0.636
Show low-probability matches.